Citadel Advisors’s SurgePays SURG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,800
Closed -$47.2K 14032
2025
Q3
$47.2K Sell
16,800
-28,500
-63% -$80.8K ﹤0.01% 12239
2025
Q2
$141K Buy
45,300
+41,300
+1,033% +$114K ﹤0.01% 11009
2025
Q1
$8.28K Buy
4,000
+3,500
+700% +$5.17K ﹤0.01% 13647
2024
Q4
$890 Sell
500
-23,200
-98% -$40.9K ﹤0.01% 14258
2024
Q3
$43.6K Sell
23,700
-9,200
-28% -$20.9K ﹤0.01% 12060
2024
Q2
$105K Sell
32,900
-59,700
-64% -$226K ﹤0.01% 10846
2024
Q1
$357K Buy
92,600
+70,100
+312% +$468K ﹤0.01% 9103
2023
Q4
$145K Buy
22,500
+9,100
+68% +$48.5K ﹤0.01% 10439
2023
Q3
$62.7K Sell
13,400
-7,900
-37% -$41K ﹤0.01% 11466
2023
Q2
$156K Buy
21,300
+12,500
+142% +$74.5K ﹤0.01% 10282
2023
Q1
$39.5K Buy
8,800
+8,200
+1,367% +$44.2K ﹤0.01% 12446
2022
Q4
$3.94K Buy
+600
New +$3.62K ﹤0.01% 14156

Other funds holding SURG

Citadel Advisors's SURG Position: Q1 2025 in Review

Citadel Advisors sold out of SurgePays (SURG) in Q1 2025, closing a stake of 41,486 shares — an estimated $61.2K sold.

Citadel Advisors first reported a position in SURG in Q4 2021 and held it in 5 quarters. The position peaked at $96.3K in Q2 2023. 29 funds tracked by Wall St. Rank hold SURG as of Q1 2025.

  • Citadel Advisors reported no remaining SurgePays position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 41,486 SurgePays shares in Q1 2025, an estimated $61.2K.
  • Citadel Advisors first reported a position in SurgePays in Q4 2021 and held it in 5 quarters.
  • Citadel Advisors's SurgePays position peaked at $96.3K in Q2 2023.
  • 29 funds tracked by Wall St. Rank held SurgePays as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.